BioSpace News Archive

ReadCoor announced a grant from the Chan Zuckerberg Initiative (CZI) and DAF, an advised fund of Silicon Valley Community Foundation, to spatially map cortical cells using Fluorescent in situ Sequencing (FISSEQ) for the Human Cell Atlas.

Jan. 3, 2018 12:00 UTC Can-Fite Enters into Collaborative Research Agreement with Hadassah Medical Center to Further Explore Namodenoson Mechanism of Action in NASH Namodenoson improves steatosis, inflammation and ballooning in pre-clinical studies A Phase II study of Namodenoson is enrolling NAFLD/NASH patients PETACH TIKVA, Israel--( BUSINESS WIRE )-- Can-Fite BioPharma Lt

W. L. Gore & Associates announced the first implant of the GORE EXCLUDER Conformable AAA Endoprosthesis in the United States.

The iStent infinite is designed for use as a standalone procedure to reduce elevated intraocular pressure (IOP) in refractory glaucoma patients.

The new CEO has over 30 years of diversified sales, marketing, and general management experience in the life sciences arena.

This approval paves the way for the company’s application to the Israel MoH for the treatment of ALS patients in Israel for a fee, under the newly introduced Hospital Exemption regulation.

Financial terms were not disclosed.

Ms. Arnold, who brings more than 20 years of experience in human resources to Kaleido, will report directly to chief executive officer and chair, Michael Bonney.

Ardelyx today announced that the company successfully completed the safety extension portion of its Phase 3 T3MPO program, designed to support the registration of tenapanor for the treatment of patients with IBS-C.

The approval of Xiidra is supported by the largest development program globally to-date for an investigational-stage dry eye disease therapy, consisting of five clinical trials with more than 2,500 patients.